Celimmune Commences Screening in Phase 2 Clinical Study in Refractory Celiac Disease Type II
Multinational study to evaluate the potential of Anti-IL-15 antibody, AMG 714, to treat rare in situ small bowel T cell ymphoma.
x
Opt-in to stay up-to-date on the latest news.
Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
Multinational study to evaluate the potential of Anti-IL-15 antibody, AMG 714, to treat rare in situ small bowel T cell ymphoma.
Glutenase for in-vivo gluten degradation is a leading candidate for celiac disease
Promising compound to begin phase 3 clinical trials for treatment of celiac disease.
The Celiac Center at Beth Israel Deaconess Medical Center (BIDMC) is conducting a research study on "brain fog."
The Celiac Center at Beth Israel Deaconess Medical Center (BIDMC) is conducting a study for people who still have stomach symptoms.
A survey is being conducted on the effects of the gluten-free fad diet.
The following press release explains a new partnership that is looking to develop a pharmaceutical treatment for celiac disease.
Several studies have been conducted to examine a possible connection between the time of gluten introduction to infants and the risk of developing celiac disease.
Investigators at the Celiac Disease Center at Columbia University have found that, despite cognitive effects reported by celiac disease patients, there is no increased risk for dementia before or after a celiac disease diagnosis.
Researchers are seeking children and adolescents with celiac disease to participate in a research study that involves a one-time, in-person interview.
Researchers at the University of Oslo have developed a blood test that provides a rapid, painless and easier celiac disease diagnosis – even for those already on a gluten-free diet
The National Foundation for Celiac Awareness (NFCA) recently covered a study that is exploring the main cause behind celiac disease.
The origins of celiac disease have remained a mystery, but today researchers are making progress on what may cause this condition to develop.
People with celiac disease have an increased risk for developing pneumonia, particularly in their first year after diagnosis.
According to the Norwegian Institute of Public Health, children who have frequent infections in their first 18 months of life have an increased risk of later developing celiac disease.
A recent study examined the hypothesis that a person would better cope with celiac disease if they practiced self-compassion and, as a result, would experience an improved quality of life and be more adherent with the gluten-free diet.
Research to inform therapeutic and diagnostic development for patients of all ages
Research examines celiac disease diagnosis recommendations.
Experts Joseph A. Murray, MD, Mayo Clinic and Daniel A. Leffler, MD, MS, BIDMC weigh in on the misconceptions that enzymes can treat or aid in managing celiac disease.
To get more information on this groundbreaking study, the National Foundation for Celiac Awareness (NFCA) got in touch with Angel Cebolla, PhD, CEO of Biomedal S.L. (ACR).
A research study presented at the 16th International Celiac Disease Symposium (ICDS) shows that gluten presence in urine correlates with mucosal damage.
NFCA recaps information from Dr. Govind Makharia, MD presented at the 16th International Celiac Disease Symposium (ICDS).
In the June/July 2015 issue of the American Gastroenterological Association's magazine, "Perspectives," celiac disease experts Sonia Kupfer, MD and Daniel Leffler, MD, MS provide an overview of the landmark GREAT3 Workshop and what it means for people with the genetic autoimmune disease.
Cour Pharmaceuticals discusses recent study data the the 16th International Celiac Disease Symposium (ICDS).
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to